0000899243-22-017502.txt : 20220510
0000899243-22-017502.hdr.sgml : 20220510
20220510185404
ACCESSION NUMBER: 0000899243-22-017502
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220506
FILED AS OF DATE: 20220510
DATE AS OF CHANGE: 20220510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Resnick Joshua
CENTRAL INDEX KEY: 0001690959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41374
FILM NUMBER: 22911514
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PepGen Inc.
CENTRAL INDEX KEY: 0001835597
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 703-456-8000
MAIL ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-06
0
0001835597
PepGen Inc.
PEPG
0001690959
Resnick Joshua
C/O PEPGEN INC.
245 MAIN STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
12.00
2022-05-06
4
A
0
11667
0.00
A
2032-05-05
Common Stock
11667
11667
D
This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.
Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"), and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund, the Nexus Fund II, and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock."
/s/ Noel Donnelly, as Attorney-in-Fact
2022-05-10